Unknown

Dataset Information

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.


ABSTRACT:

Background

Neurologic manifestations are well-recognized features of coronavirus disease 2019 (COVID-19). However, the longitudinal association of biomarkers reflecting CNS impact and neurological symptoms is not known. We sought to determine whether plasma biomarkers of CNS injury were associated with neurologic sequelae after COVID-19.

Methods

Patients with confirmed acute COVID-19 were studied prospectively. Neurological symptoms were recorded during the acute phase of the disease and at six months follow-up, and blood samples were collected longitudinally. Healthy age-matched individuals were included as controls. We analysed plasma concentrations of neurofilament light-chain (NfL), glial fibrillary acidic protein (GFAp), and growth differentiation factor 15 (GDF-15).

SUBMITTER: Kanberg N 

PROVIDER: S-EPMC8320425 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature